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The elastase-inhibitory activity of a,-antiproteinase is inactivated by hydroxyl radicals (‘OH) generated by pulse radio- 
lysis or by reaction of iron ions with H,O, in the presence of superoxide or ascorbate. Uric acid did not protect a,-antipro- 
teinase against inactivation by bH in pulse radiolysis experiments or in the superoxide/iron/H,O, system, whereas it 
did in systems containing ascorbic acid. We propose that radicals formed by attack of bH on uric acid are themselves 
able to inactivate a,-antiproteinase, but that these uric acid radicals can be ‘repaired’ by ascorbic acid. 
Uric acid; Hydroxyl radical; Peroxy radical; Antiproteinase, a,- 
1. INTRODUCTION 
There has been much interest recently in the 
possible role played by oxidants in human disease, 
and in the protective effects of endogenous antiox- 
idants [l-3]. It has been proposed that uric acid, an 
end-product of purine metabolism in man, may 
function as an antioxidant in vivo [4,5]. Indeed, 
measurement of oxidation products of uric acid 
may be a marker of oxidant generation in vivo 
[6,7]. Experiments in vitro have shown that uric 
acid protects erythrocytes against damage by 
singlet 02 or t-butyl hydroperoxide 141, inhibits 
lipid peroxidation [8-lo], decreases oxidation of 
haemoglobin by nitrite [ 111, inhibits oxidative 
degradation of hyaluronic acid [12], scavenges the 
myeloperoxidase-derived oxidant hypochlorous 
acid [ 13,141, protects against oxidant damage to 
DNA [ 151, inhibits ozone-induced degradation of 
nucleic acid bases [16] and binds iron and copper 
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ions in complexes that are poorly active in pro- 
moting free radical reactions [ 17,181. Uric acid also 
scavenges (k2 7.2 x lo9 M-’ ‘s-l) hydroxyl 
radicals [19], and can protect certain enzymes 
against inactivation by this reactive radical species. 
However, reaction of uric acid with ‘OH yields a 
uric acid radical, that can probably combine with 
02 to give a peroxy radical [19]. Kittridge and 
Willson [19] reported that uric acid-derived 
radicals inactivate yeast alcohol dehydrogenase, an 
enzyme that is very sensitive to oxidants, more 
rapidly than does ‘OH, and they therefore cast 
doubt upon the proposed antioxidant role of uric 
acid [4,5]. 
However, uric acid is thought to act as an antiox- 
idant in humans [4,5], who do not possess a yeast- 
type alcohol dehydrogenase. One protein in 
humans that is very sensitive to oxidants is 
ar-antiproteinase, the major circulating inhibitor 
of proteolytic enzymes uch as elastase [20,21]. In- 
activation of al-antiproteinase can apparently ex- 
acerbate tissue damage in several diseases, in- 
cluding rheumatoid arthritis and emphysema 
120-241. The protein can be inactivated by hypo- 
chlorous acid [22-25,271, oxidizing species (pro- 
bably peroxynitrates) in cigarette smoke [26] and 
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hydroxyl radical [23,24,26]. We have therefore ex- 
amined the ability of uric acid to protect ai-anti- 
proteinase against inactivation by hydroxyl 
radicals (‘OH) generated either by radiolysis of 
aqueous solutions, or from Hz02 in the presence of 
iron ions and either ascorbic acid or a system 
generating the superoxide radical, Or. 
2. MATERIALS AND METHODS 
Dimethyl sulphoxide and pig pancreatic elastase were from 
BDH; all other reagents (including uric acid) were of the highest 
quality available from Sigma. The ability of purified or-anti- 
proteinase (Sigma type A9024) to inhibit elastase was assayed 
essentially as in [28]: full details are given in the legend to table 
1. Generation of ‘OH by the hypoxanthine/xanthine oxidase 
system was carried out essentially as described 1381; full details 
are given in the legend to table 3. Generation of ‘OH by the iron- 
EDTA/HzOz/ascorbic acid system was carried out essentially as 
in [3 I]; details are given in the legend to table 2. Pulse radiolysis 
was carried out using the Paterson Laboratories linear ac- 
celerator facility in a continuous pulsing mode (50 pulses/s 1291. 
Solutions of crt-antiproteinase (1 mg/ml) in NzO-saturated 10 
mM KHzPOd-KOH buffer (pH 7.4) were subjected to 30 krad 
over approx. 6 min to generate 180 pmoI/dm’ of ‘OH overall. 
The yield of ‘OH was calibrated daily using a Fricke dosimeter. 
3. RESULTS 
3.1. Generation of hydroxyl radicals by radiolysis 
Irradiation of a dilute aqueous (10 mM 
KHzPOd-KOH buffer, pH 7.4) solution saturated 
with nitrous oxide produces ‘OH 
H2Ow ‘OH, e-caa. H’, H202, HZ (1) 
e-caa + NzO + Hz0 --t ‘OH + OH- + NZ (2) 
If ai-antiproteinase (1 mg/ml, approx. 19pM) was 
included in the radiolysis solution, it was inac- 
tivated (table 1). Generation of 180 pmol/dm3 of 
‘OH over about a 6-min period produced a 
substantial loss of activity of cri-antiproteinase, 
measured as its ability to inhibit elastase (table 1). 
Several compounds able to scavenge ‘OH protected 
the ai-antiproteinase, so that its elastase-inhibitory 
capacity was retained. Table 1 shows an example: 
protection by indomethacin and piroxicam, which 
scavenge ‘OH with rate constants close to IO” 
M-i . s-’ [30]. Despite its ability to scavenge ‘OH, 
Table 1 
Inactivation of cut-antiproteinase by hydroxyl radicals :radiolysis 
Expt 
(A) 
Unirradiated (rtAP 
Irradiated rvtAP 
+ 240 pM indomethacin 
+ 240 PM piroxicam 
+ 120 FM uric acid 
+ 240pM uric acid 
Elastase activity cut-Antiproteinase 
(x 10-z s-1) activity (as % 
(A&o) inhibition of elastase) 
0 100 
1.33 13 
0.66 57 
0.76 50 
1.29 16 
1.48 3 
(B) 
Irradiated at AP 
+ 240 PM indomethacin 
+ 240 pM piroxicam 
+ 120~M uric acid 
+ 240~M uric acid 
0.69 55 
0.76 50 
1.58 0 
1.50 2 
All concentrations listed are final concentrations in the reaction mixtures. cYi-Antiproteinase 
((r,AP, 1 mg/ml) in phosphate buffer was subjected to radiolysis over about a 6 min period 
with 30 krad to generate lSO/lmol OH/dm’. Immediate after radiolysis, a sample (0.1 mg) of 
(rtAP was incubated with porcine pancreatic elastase for 30 min at 25°C. The residual elastase 
activity was then measured by adding elastase substrate [28], which is hydrolysed by elastase 
with a rise in 4410. Elastase alone (not exposed to LYIAP) gave a AA410 of 1.53 x lo-’ s-r. A 
concentration of orAP just sufficient to inhibit elastase activity completely was used in the 
control experiment. Experiments were performed in buffer saturated with NzO (A) or with 
80% (v/v) N20/200/0 (v/v) 02 (B) 
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Table 2 
Inactivation of crt-antiproteinase by hydroxyl radicals: ascorbate/iron/H202 system 
Expt Elastase activity cut-Antiproteinase activity 
(A&o) (x lo-* s-‘) (1% inhibition of elastase) 
cu,-Antiproteinase alone 0 100 
Complete reaction mixture 1.17 3 
(omit Fe3+-EDTA) 0.3 75 
+ 400 pM dimethyl sulphoxide 0.65 46 
+ 200 pM uric acid 0.52 57 
+ 400 pM uric acid 0.37 69 
Reaction mixtures contained, in a final volume of 1 ml, the following reagents at the final con- 
centrations stated: 10 mM KHzPOd-KOH buffer (pH 7.4), 0.2 mM ascorbic acid, 0.1 mM 
Fe’+-EDTA, 2.8 mM Hz02 and 1 mg/ml at-antiproteinase. Solutions of ascorbic acid and 
FeCI3 were made up fresh immediately before use. After incubation at 37°C for 1 h, an aliquot 
of the assay mixture was added to a cuvette containing 0.05 ml elastase (BDH, 1 mg/ml, 
freshly diluted). After standing for 20 min, the residual elastase activity was measured (see [28] 
and legend to table 1). The elastase alone gave a AA410 of 1.2 x lo-* s-’ 
uric acid had almost no protective effect in this 
system (table 1). 
If the solution is bubbled with an 80% N20/20% 
02 mixture instead of pure N20, the radicals pro- 
duced by attack of ‘OH on added ‘scavengers’ will 
be able to form peroxy radicals, i.e. if X is the 
scavenger 
‘OH 
x-x. 02 x02. 
Table 1 shows that indomethacin and piroxicam (as 
well as most other ‘OH scavengers tested) were still 
protective under these conditions. However, uric 
acid accelerated the inactivation of ai-anti- 
proteinase: more of its elastase-inhibitory capacity 
was lost upon irradiation in the presence of uric 
acid. 
3.2. Generation of hydroxyl radicals by 
biochemical systems 
A mixture of Fe3+-EDTA, Hz02 and ascorbic 
acid at pH 7.4 generates ‘OH [31,38]. If ai-anti- 
Table 3 
Inactivation of at-antiproteinase by hydroxyl radicals: hypoxanthine/xanthine oxidase/iron 
system 
Expt 
cut-Antiproteinase alone 
Complete reaction mixture 
(omit FeCI,-EDTA) 
+ 1 mM DMSO 
+ 1 mM uric acid 
+ 100 pM ascorbic acid 
+ 100 pM ascorbic acid and 
1 mM DMSO 
+ 100 PM ascorbic acid and 
1 mM uric acid 
Elastase activity cut-Antiproteinase activity 
(AAao) (X IO-’ SC’) (o/o inhibition of elastase) 
0 100 
7.1 6 
0 100 
4.5 45 
8.2 0 
5.9 28 
2.5 70 
4.3 48 
Reaction mixtures contained, in a final volume of 1 ml, the following reagents at the final con- 
centrations stated: 10 mM KHzPOI-KOH buffer (pH 7.4), 1 mg/ml cut-antiproteinase, 1OOpM 
Fe3+-EDTA, 333 pM hypoxanthine and 0.033 U/ml of Sigma xanthine oxidase. Incubation 
was at 31°C for 1 h. An aliquot of the assay mixture was added to a cuvette containing elastase 
as described in the legend to table 2. The elastase alone gave a AA410 of 8.2 x lo-’ s-‘. Solu- 
tions of ascorbate and FeCls were made up fresh before use 
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proteinase was incubated with this reaction mix- the high uric acid: ai-antiproteinase molar ratios 
ture, its elastase-inhibitory capacity was diminish- used (19/rM protein, 120-240,uM uric acid), almost 
ed. Several scavengers of ‘OH offered protection: all of the ‘OH generated would react with the uric 
table 2 shows an example for dimethyl sulphoxide acid. Hence, the inactivation is presumably 
(kz for reaction with ‘OH about 7 x lo9 M-’ . s-’ mediated by uric acid-derived carbon-centred and 
[31]). Uric acid was reproducibly protective in this peroxy radicals which appear, in the latter case 
system (table 2 shows a typical result): there was especially, to be more effective at activating 
less inactivation of ai-antiproteinase in the a,-antiproteinase than is ‘OH under our reaction 
presence of uric acid. conditions. 
A mixture of hypoxanthine and xanthine oxidase 
generates OZ- and Hz02 [32] which can form ‘OH 
if iron ions are present [38]. Such a reaction mix- 
ture also inactivated the elastase-inhibitory capaci- 
ty of ai-antiproteinase (table 3). Protection was af- 
forded by several scavengers of ‘OH, such as 
dimethyl sulphoxide (table 3), or by omission of 
iron from the reaction mixture. Uric acid did not 
protect cui-antiproteinase: in fact, it slightly but 
reproducibly increased the inactivation. Addition 
of ascorbic acid to the reaction mixture slightly 
protected the cui-antiproteinase: it has been ob- 
served previously that addition of ascorbic acid to 
the hypoxanthine/xanthine oxidase/FeCL-EDTA 
system does not significantly increase the total 
amount of ‘OH generated [38]. However, in the 
presence of ascorbate, further addition of uric acid 
reproducibly decreased inactivation of al-anti- 
proteinase (table 3 shows a typical experimental 
result). Control experiments howed that none of 
these reagents affected the activity of xanthine ox- 
idase under our reaction conditions. 
Inactivation of ai-antiproteinase by ‘OH 
generated in a hypoxanthine/xanthine ox- 
idase/iron system, a biologically relevant source of 
‘OH [34,38], has also been demonstrated. Again, 
uric acid enhanced the inactivation, whereas other 
‘OH scavengers protected (table 3). By contrast, 
when ‘OH was generated by the ascorbate/HzOz/ 
iron system, ai-antiproteinase was inactivated but 
uric acid offered protection (table 2). Similarly, 
when ascorbic acid was added to the hypo- 
xanthine/xanthine oxidase/iron system, further 
addition of uric acid protected the crr-anti- 
proteinase. Why should there be this difference? 
Maples and Mason [35] reported that a uric acid: 
derived radical could be reduced back to uric acid 
in a ‘repair’ reaction. Thus, by such reactions as 
urate’ + ascorbic acid + urate + 
semidehydroascorbate + H+ 
urate 02 + ascorbic acid + urate 02H + 
(4) 
semidehydroascorbate (5) 
4. DISCUSSION 
Kittridge and Willson [19] reported that various 
radicals produced by attack of ‘OH, generated by 
pulse radiolysis, upon uric acid are able to inac- 
tivate the enzyme yeast alcohol dehydrogenase, 
which is known to be very sensitive to oxidant 
damage [33]. Here, we have shown directly that 
‘OH radicals are also able to inactivate cui-anti- 
proteinase, in confirmation of previous conclu- 
sions based upon the use of scavengers [23,24,26]. 
ui-Antiproteinase is the major circulating inhibitor 
of serine proteases such as elastase and its inacti- 
vation, e.g. in the lung or at sites of inflammation, 
can have severe biological consequences [20-261. 
Uric acid, especially in the presence of 02 to allow 
formation of urate peroxy radicals, exacerbated 
the inactivation of rui-antiproteinase by ‘OH. At 
the urate and urate peroxy radicals can be removed 
and the ability of uric acid to scavenge ‘OH then 
allows it to protect al-antiproteinase. It should be 
noted that iron was used chelated to EDTA in all 
these experiments, so that the ability of uric acid to 
bind metal ions [ 17,181 could not interfere with the 
‘OH generation. 
What is the physiological significance of these 
observations in humans? Uric acid is present at 
concentrations up to 5OO/rM in body fluids and ap- 
pears to break down at an increased rate when ox- 
idants are generated, e.g. at sites of inflammation 
[6,7]. On the other hand, ascorbic acid is also pre- 
sent in extracellular fluids, although the amounts 
may decrease under conditions of oxidant stress 
[36,37]. In view of the many other oxidant- 
scavenging properties of uric acid (section l), it 
seems likely that its overall effect will be protective. 
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However, the results obtained in [19] and in the 
present paper remind us that no antioxidant is 
perfect [ 11. 
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